Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

Advertisement

Top Coronary Artery Disease News in 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content